Speciality
· Gamma Knife and CyberKnife treatment for:
- Acoustic neuromas, trigeminal schwannomas, and small-to-medium skull base meningiomas under 3CM.
- Cavernous sinus meningiomas, residual postoperative meningiomas, small pituitary adenomas, and residual postoperative pituitary tumors.
- Small cerebral arteriovenous malformations (AVMs), brain metastases.
- Chordomas, pineal region tumors, hemangioblastomas, jugular foramen tumors.
- Selected small low-grade gliomas, various residual brain tumors after neurosurgery.
- CyberKnife treatment for recurrent malignant gliomas after surgery, radiotherapy, or chemotherapy.
CyberKnife treatment for:
- Lung cancer, lung metastases, small liver cancers, liver metastases, pancreatic cancer.
- Retroperitoneal lymph node metastases, prostate cancer, bone metastases (especially spinal vertebral metastases).
- Neurofibromas in the intervertebral foramen or paravertebral region, and spinal AVMs (spinal arteriovenous malformations).
Profile
Graduated from Henan Medical University in 1985 and subsequently worked in the Neurosurgery Department of its Second Affiliated Hospital. Enrolled in the Master's program at Henan Medical University in 1988, studying under Professor Su Fangzhong, and obtained a Master's degree in 1991.
Enrolled in the Doctorate program at Shanghai Medical University Huashan Hospital in 1993, studying under Academician Zhou Liangfu, a renowned neurosurgery expert in China, and began radiosurgery treatment (Gamma Knife therapy) and research.
Obtained a Doctoral degree in 1996 and remained working at Huashan Hospital. He is the first doctorate holder in China specializing specifically in Gamma Knife treatment and research. Under the guidance of Academician Zhou Liangfu and Professor Pan Li, his work "Gamma Knife Radiobiological Experiment and Clinical Research and Its Significance" received the Shanghai Science and Technology Progress Third Prize.
Began Gamma Knife practice and research in 1993, emphasizing patient follow-up to continuously refine treatment strategies, accumulating extensive experience. Promoted to Associate Professor in 1999. From 2000-2001, funded by a government scholarship, he advanced his neurosurgical training at The National Hospital for Neurology and Neurosurgery, University College London, under world-renowned neurosurgeon Professor David Thomas, Vice-President of the World Federation of Neurosurgical Societies.
Co-authored with Professor Pan Li the paper "Long-term outcomes of Gamma Knife surgery for trigeminal schwannoma," published in the Journal of Neurosurgery (2005). This paper was recognized as one of the top 25 most cited international papers on Gamma Knife therapy in 2009. Has participated in the treatment of over 10,000 patients with Gamma Knife, gaining vast experience in managing acoustic neuromas, meningiomas, pituitary adenomas, brain metastases, trigeminal schwannomas, hemangioblastomas, nasopharyngeal angiofibromas, chordomas, cerebral AVMs, trigeminal neuralgia, craniopharyngiomas, and jugular foramen tumors (glomus jugulare tumors, schwannomas).
After Huashan Hospital introduced the CyberKnife system in 2007, he began CyberKnife treatments, applying his Gamma Knife expertise while leveraging the unique advantages of CyberKnife. Over seven years, he treated over 12,000 patients, rapidly establishing himself as an expert in CyberKnife therapy. Joined Foshan Fosun Chancheng Hospital in 2024 as the Chief Radiation Oncologist for the Precision Tumor Diagnosis and Treatment Center.
Published over 40 papers, including 30 as first author and 8 SCI-indexed papers. Contributed chapters to several textbooks including "Practical Surgery," "Modern Neurosurgery," "Neurosurgery," "Modern Functional Neurosurgery," "Modern Neurosurgery Handbook," "Neurosurgical Techniques," "Neuronavigation," and "Glioma."
Academic Achievements
· "Experimental and Clinical Research on Gamma Knife Radiobiology and Its Significance" awarded the Shanghai Science and Technology Progress Third Prize (1998).
· "Basic and Clinical Research on Central Nervous System Hemangioblastoma" awarded the Chinese Medical Science and Technology Fifth Prize (Fifth Contributor, 2007).
· "Basic, Clinical Diagnosis and Treatment of Central Nervous System Hemangioblastoma" awarded the Shanghai Science and Technology Progress First Prize (Fifth Contributor, 2007).
· "Minimally Invasive Treatment and Related Basic Research of Central Nervous System Hemangioblastoma" awarded the Ministry of Education Science and Technology Progress Second Prize (Fifth Contributor, 2008).
· Chief Editor of the leading CyberKnife monograph "CyberKnife Radiosurgery."
· Contributor to the international authoritative work "CyberKnife Neuro-Radiosurgery."
Dr. Wang Enmin being interviewed by renowned media at a Radiosurgery Summit Forum.
Professor Wang Enmin sharing CyberKnife treatment experience at the Foshan Chancheng Hospital Tumor Center.
Professor Wang Enmin patiently explaining treatment plans to a patient.
Professor Wang Enmin delivering a speech at the Radiosurgery Summit Forum.
